Curanex Pharmaceuticals Inc Common Stock
General ticker "CURX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $62.6M (TTM average)
Curanex Pharmaceuticals Inc Common Stock does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 7.9%: low 0.45$, high 0.52$
Short-term CURX quotes
Long-term CURX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $0.02MM | $0.37MM | $4.24MM |
| Operating Income | $-0.02MM | $-0.37MM | $-4.24MM |
| Non-Operating Income | $0.00MM | $0.00MM | $0.01MM |
| Interest Expense | $0.00MM | $0.00MM | $0.01MM |
| R&D Expense | $0.00MM | $0.00MM | $2.99MM |
| Income(Loss) | $-0.02MM | $-0.36MM | $-4.23MM |
| Profit(Loss)* | $-0.02MM | $-0.36MM | $-4.23MM |
| Stockholders Equity | $0.06MM | $0.50MM | $11.22MM |
| Assets | $0.07MM | $0.52MM | $11.58MM |
| Operating Cash Flow | $-0.00MM | $-0.56MM | $-10.48MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.07MM | $0.63MM | $15.31MM |
| Earnings Per Share** | $-0.00 | $-0.01 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.